Senior Manager, CRM Systems Administration
Axsome Therapeutics Inc- Full Time
- Senior (5 to 8 years)
Freenome is a high-growth biotech company dedicated to detecting cancer in its earliest, most treatable stages through a multiomics platform that combines tumor and non-tumor signals with machine learning. Our mission is to impact patients by empowering everyone to prevent, detect, and treat their disease. We are seeking a Staff Business Solutions Engineer (ITBP) to act as a strategic liaison between assigned business units and IT. This role focuses on technology strategy development, solution discovery, service management, risk management, and relationship management, providing high-level consulting support for key IT initiatives.
Freenome is a high-growth biotech company developing tests to detect cancer using a standard blood draw. To do this, Freenome uses a multiomics platform that combines tumor and non-tumor signals with machine learning to find cancer in its earliest, most-treatable stages. Cancer is relentless. This is why Freenome is building the clinical, economic, and operational evidence to drive cancer screening and save lives. Our first screening test is for colorectal cancer (CRC) and advanced adenomas, and it’s just the beginning. Founded in 2014, Freenome has ~400 employees and continues to grow to match the scope of our ambitions to provide access to better screening and earlier cancer detection. At Freenome, we aim to impact patients by empowering everyone to prevent, detect, and treat their disease. This, together with our high-performing culture of respect and cross-collaboration, is what motivates us to make every day count.
A “Freenomer” is a determined, mission-driven, results-oriented employee fueled by the opportunity to change the landscape of cancer and make a positive impact on patients’ lives. Freenomers bring their diverse experience, expertise, and personal perspective to solve problems and push to achieve what’s possible, one breakthrough at a time.
Biotechnology company for early cancer detection
Freenome focuses on improving cancer detection through advanced blood tests. The company uses a multiomics approach, analyzing various biological data types, including genomics and proteomics, to find cancer markers in blood samples. This method allows for non-invasive early detection of cancer, which is crucial for effective treatment. Freenome differentiates itself from competitors by its unique combination of data analysis techniques and its commitment to clinical trials and research collaborations. The company's goal is to enhance cancer diagnostics and make early detection accessible to healthcare providers and patients, ultimately aiming to save lives through timely intervention.